Society of Nuclear Medicine and Molecular Imaging (SNMMI) | Strategic Alliance Partners
Latest from Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Establishing guideline harmonization and practice standardization may help promote the safe and consistent delivery of radiopharmaceutical therapies.
89Zr-DFO-daratumumab shows activity in identifying and localizing multiple myeloma, even in FDG-non-avid cases, per new phase 2 data.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA MCGP Panel Votes in Favor of the Galleri Multicancer Early Detection Test
2
FDA Grants Approval to Lirafugratinib for Advanced Cholangiocarcinoma with FGFR2 Alteration
3
Belzutifan Combo Receives FDA Approval in Advanced Clear Cell RCC
4
Approaching Cardiovascular Risk in Prostate Cancer Hormonal Therapy
5